DHR vs TECH
DHR: Danaher is a diversified conglomerate providing scientific instruments, diagnostics, and industrial solutions across life sciences, environmental monitoring, product identification, and healthcare globally. TECH: Bio-Techne provides the essential tools, reagents, and instruments fueling scientific discovery, advanced diagnostics, and cell and gene therapy manufacturing.
Side-by-side fundamentals
| Metric | DHR | TECH | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $218.85 | $72.32 | |
| Market cap as of 2026-08-24 | $153.8B | $11.3B | |
| P/E as of 2026-08-24 | 35.89 | 104.27 | DHR lower |
| PEG as of 2026-08-24 | 3.74 | 16.36 | DHR lower |
| Net margin as of 2026-08-24 | +15.9% | +9.0% | DHR higher |
| Gross margin as of 2026-08-24 | +58.6% | +66.4% | TECH higher |
| Operating margin as of 2026-08-24 | +20.4% | +12.7% | DHR higher |
| ROE as of 2026-08-24 | +7.7% | +5.4% | DHR higher |
| ROA as of 2026-08-24 | +4.7% | +4.3% | DHR higher |
| Debt / equity as of 2026-08-24 | 0.51 | 0.10 | TECH lower |
| Revenue growth (YoY) as of 2026-08-24 | +4.6% | +0.2% | DHR higher |
| Revenue CAGR (3y) SEC XBRL | -2.7% | +3.3% | TECH higher |
| Dividend yield as of 2026-08-24 | +0.5% | +0.5% | TECH higher |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-24 | 0.78 | 1.30 | |
| 1-year return as of 2026-08-21 close | +7.3% | +33.9% | TECH higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.